TP53 and neoplasm: The results of the GSEA showed that several immune and tumor-related pathways were involved in the high-risk group, such as JAK-STAT signaling pathway, Antigen processing and presentation, Leukocyte transendothelial migration, B cell activation involved in immune response, integrin mediated signaling pathway and p53 signaling pathway.